Versant Capital Management, Inc Merck & Co., Inc. Transaction History

Versant Capital Management, Inc

$431 Million
Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,214 shares of MRK stock, worth $217,769. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,214

Previous 1,841 20.26%

Holding current value

$217,769

Previous $227,000 10.57%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$111.15 - $128.97 $41,458 - $48,105	373 Added 20.26%	2,214 $251,000
Q2 2024 Jul 05, 2024	BUY	$123.8 - $132.96 $114,143 - $122,589	922 Added 100.33%	1,841 $227,000
Q4 2023 Jan 08, 2024	SELL	$100.18 - $109.02 $100 - $109	-1 Reduced 0.11%	919 $100,000
Q3 2023 Oct 11, 2023	SELL	$102.95 - $114.33 $617 - $685	-6 Reduced 0.65%	920 $94,000
Q2 2023 Jul 10, 2023	BUY	$108.61 - $118.38 $10,317 - $11,246	95 Added 11.43%	926 $106,000
Q4 2022 Jan 25, 2023	SELL	$87.44 - $112.11 $262 - $336	-3 Reduced 0.36%	831 $0
Q1 2022 Apr 29, 2022	SELL	$73.51 - $82.4 $514 - $576	-7 Reduced 0.83%	834 $68,000
Q3 2021 Oct 29, 2021	SELL	$71.68 - $78.83 $3,727 - $4,099	-52 Reduced 5.82%	841 $63,000
Q2 2021 Jul 22, 2021	SELL	$70.31 - $77.77 $62,013 - $68,593	-882 Reduced 49.69%	893 $69,000
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $206 - $243	3 Added 0.17%	1,775 $137,000
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $717 - $796	-10 Reduced 0.56%	1,772 $144,000
Q2 2020 Jul 16, 2020	SELL	$70.42 - $80.13 $915 - $1,041	-13 Reduced 0.72%	1,782 $137,000
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $14,636 - $20,286	-231 Reduced 11.4%	1,795 $138,000
Q4 2019 Jan 28, 2020	SELL	$77.58 - $87.54 $1,706 - $1,925	-22 Reduced 1.07%	2,026 $184,000
Q3 2019 Oct 18, 2019	SELL	$76.08 - $82.93 $989 - $1,078	-13 Reduced 0.63%	2,048 $172,000
Q2 2019 Jul 16, 2019	SELL	$69.84 - $81.59 $47,211 - $55,154	-676 Reduced 24.7%	2,061 $172,000
Q1 2019 Apr 23, 2019	BUY	$69.58 - $79.36 $174,645 - $199,193	2,510 Added 1105.73%	2,737 $227,000
Q1 2019 Apr 23, 2019	SELL	$69.58 - $79.36 $177,707 - $202,685	-2,554 Reduced 91.84%	227 $227,000
Q3 2018 Oct 15, 2018	SELL	$57.69 - $67.84 $5,884 - $6,919	-102 Reduced 3.54%	2,781 $197,000
Q2 2018 Jul 06, 2018	BUY	$50.83 - $59.72 $2,439 - $2,866	48 Added 1.69%	2,883 $174,000
Q1 2018 Apr 19, 2018	SELL	$50.96 - $59.23 $25,989 - $30,207	-510 Reduced 15.25%	2,835 $154,000
Q4 2017 Apr 19, 2018	BUY	$51.62 - $61.64 $19,047 - $22,745	369 Added 12.4%	3,345 $188,000
Q3 2017 Apr 23, 2018	SELL	$58.67 - $63.13 $7,157 - $7,701	-122 Reduced 3.94%	2,976 $190,000
Q2 2017 Apr 23, 2018	SELL	N/A	-6 Reduced 0.19%	3,098 $198,000
Q4 2016 Apr 23, 2018	SELL	N/A	-195 Reduced 5.91%	3,104 $182,000
Q3 2016 Apr 23, 2018	BUY	N/A	22 Added 0.67%	3,299 $205,000
Q2 2016 Apr 23, 2018	SELL	N/A	-126 Reduced 3.7%	3,277 $188,000
Q1 2016 Apr 23, 2018	SELL	N/A	-76 Reduced 2.18%	3,403 $180,000
Q4 2015 Apr 23, 2018	BUY	N/A	3,479	3,479 $183,000

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Merck & Co., Inc. Transaction History